Britov A N, Bystrova M M
Research Center for Preventive Medicine: Petroverigsky per. 10, 101953 Moscow, Russia.
Kardiologiia. 2003;43(11):93-7.
Need for update of guidelines of the Joint National Committee (USA) on Prevention, Diagnosis and Management of Hypertension was based on necessity to adopt changes based on results of recent studies as well as creation of more simple and convenient variant for practical physicians. Compared with JNC VI most important changes concerned classification of blood pressure (BP) levels and approaches to drug therapy. New category "prehypertension" was introduced and 2 stages of hypertension distinguished: stage I - systolic BP 140-159 mm Hg or diastolic 90-99 mm Hg, stage II - systolic BP 160 mm Hg or higher, diastolic BP 100 mm Hg or higher. Diuretics were recommended as drugs of first choice and wider use of drug combinations encouraged. Some statements of JNC VII report have been criticized by some hypertension authorities.
美国国家联合委员会关于高血压预防、诊断和管理指南需要更新,这是基于根据近期研究结果进行调整的必要性,以及为临床医生创建更简单便捷版本的需求。与JNC VI相比,最重要的变化涉及血压(BP)水平分类和药物治疗方法。引入了新的“高血压前期”类别,并区分了高血压的两个阶段:I期——收缩压140 - 159毫米汞柱或舒张压90 - 99毫米汞柱,II期——收缩压160毫米汞柱及以上,舒张压100毫米汞柱及以上。推荐利尿剂作为首选药物,并鼓励更广泛地使用联合用药。JNC VII报告的一些陈述受到了一些高血压领域权威人士的批评。